Fundraising FoxDiamond Biofund
Venture capitalTaipei · Seed–Series B · 6 people tracked
Find your way into Diamond Biofund
Sign up to see every warm intro you have to Diamond Biofund
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diamond Biofund team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Diamond Biofund positions itself as a sustainability-focused biotech venture capital firm aiming to identify top investment targets and maximize returns. It seeks out leading scientists in the life sciences and provides comprehensive professional resources, leveraging more than 25 years of new-drug R&D experience to help technologies succeed commercially and move from laboratory to market. The firm co-invests with large financial holding groups in a sustainable biotech fund to build flagship biotech enterprises, emphasizing precise investment and efficient support to grow portfolio companies' market value and deliver maximized returns for shareholders.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from the firm's website & public directoriesAcademician of Academia Sinica and former President of National Taiwan University, where he was also a professor of internal medicine. Previously led the Institute for Biotechnology and Medicine Industry.
Former Managing Director of China Dynamic Growth Fund in Hong Kong and General Manager of H&Q Asia Pacific in China. Has served as Chairman of Starbucks Coffee Beijing and Chairman of the Board of Trustees at Taipei Medical University.
Chairman of several biotech and pharmaceutical companies including Mircobio, Oneness Biotech, CHO Pharma, and Sinew Pharma.
Investor relations contact for Diamond Biofund.
Serves as board director for several biotech companies including EyeYon, StemCyte, 3D Global Biotech, Tetantai Agribiotech, Bilayer Therapeutics, and Theia Medical.
Yolanda Wu is Senior Advisor and Head of Financial Management at the Corporate Management Center of Microbio Group, a position held since July 2026. She previously served at Diamond Biofund Inc. in roles including President, Executive Vice President and Chief Compliance Officer, and Executive Vice President and Chief Strategy Officer, and before that was CFO and Spokesperson at Ennoconn Corp. Her earlier career included roles as Director of Taiwan's Financial Supervisory Commission, Deputy Director of the FSC London Office, an auditor at Ernst & Young Taiwan, and a position at Central Trust of China, with over 30 years of experience in corporate finance and regulation.
Frequently asked questions
- What stage does Diamond Biofund invest at?
- Diamond Biofund invests at the Seed, Series A, Series B stages.
- What sectors does Diamond Biofund focus on?
- Diamond Biofund focuses on Biotech, Medical Devices.
- Where is Diamond Biofund located?
- Diamond Biofund is headquartered in Taipei, TW.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.